Condensed Consolidated Interim Statements of Changes in Shareholders' Equity (Deficiency) - USD ($) |
Total |
Preferred Stock [Member] |
Common Stock [Member] |
Additional Paid-in Capital [Member] |
Deficit [Member] |
Accumulated Other Comprehensive Income [Member] |
---|---|---|---|---|---|---|
Opening Balance at Mar. 31, 2017 | $ 24,150,650 | $ 0 | $ 96,794 | $ 45,088,171 | $ (21,076,464) | $ 42,149 |
Opening Balance (in shares) at Mar. 31, 2017 | 1 | 96,794,443 | ||||
Warrants exercised | 1,125,038 | $ 0 | $ 5,000 | 1,120,038 | 0 | 0 |
Warrants exercised (in shares) | 0 | 5,000,172 | ||||
Share compensation expense | 251,048 | $ 0 | $ 0 | 251,048 | 0 | 0 |
Share compensation expense (in shares) | 0 | 0 | ||||
Fair value of warrants on convertible loans | 204,790 | $ 0 | 204,790 | 0 | 0 | |
Net loss for the period | (2,240,518) | (2,240,518) | ||||
Closing Balance at Jun. 30, 2017 | 23,491,008 | $ 0 | $ 101,794 | 46,664,047 | (23,316,982) | 42,149 |
Closing Balance (in shares) at Jun. 30, 2017 | 1 | 101,794,615 | ||||
Opening Balance at Mar. 31, 2017 | 24,150,650 | $ 0 | $ 96,794 | 45,088,171 | (21,076,464) | 42,149 |
Opening Balance (in shares) at Mar. 31, 2017 | 1 | 96,794,443 | ||||
Closing Balance at Mar. 31, 2018 | 20,463,014 | $ 0 | $ 249,599 | 55,947,606 | (35,776,340) | 42,149 |
Closing Balance (in shares) at Mar. 31, 2018 | 1 | 249,599,986 | ||||
Opening Balance at Jun. 30, 2017 | 23,491,008 | $ 0 | $ 101,794 | 46,664,047 | (23,316,982) | 42,149 |
Opening Balance (in shares) at Jun. 30, 2017 | 1 | 101,794,615 | ||||
Warrant down round feature | 0 | $ 0 | $ 0 | 74,086 | (74,086) | 0 |
Share compensation expense | 1,289,532 | 1,289,532 | ||||
Share compensation expense (in shares) | 0 | |||||
Conversion of convertible notes | 9,180,785 | $ 0 | $ 147,805 | 9,032,980 | 0 | 0 |
Conversion of convertible notes (in shares) | 0 | 147,805,371 | ||||
Fair value of warrants on convertible loans | 343,389 | 343,389 | ||||
Stock option and warrant reclassification | (2,845,557) | $ 0 | $ 0 | (2,845,557) | 0 | 0 |
Beneficial conversion feature on convertible debt | 1,389,129 | 0 | 0 | 1,389,129 | 0 | 0 |
Net loss for the period | (12,385,272) | (12,385,272) | ||||
Closing Balance at Mar. 31, 2018 | 20,463,014 | $ 0 | $ 249,599 | 55,947,606 | (35,776,340) | 42,149 |
Closing Balance (in shares) at Mar. 31, 2018 | 1 | 249,599,986 | ||||
Share compensation expense | 595,412 | $ 0 | 595,412 | 0 | 0 | |
Share compensation expense (in shares) | 0 | 0 | ||||
Conversion of convertible notes | 2,470,622 | $ 0 | $ 39,546 | 2,431,076 | 0 | 0 |
Conversion of convertible notes (in shares) | 0 | 39,545,776 | ||||
Stock option and warrant reclassification | 1,173,534 | $ 0 | $ 0 | 1,173,534 | 0 | 0 |
Net loss for the period | (760,698) | (760,698) | ||||
Closing Balance at Jun. 30, 2018 | $ 23,941,884 | $ 0 | $ 289,145 | $ 60,147,628 | $ (36,537,038) | $ 42,149 |
Closing Balance (in shares) at Jun. 30, 2018 | 1 | 289,145,762 |